Among the above genetic changes, mutations in TET2, DNMT3A, and RHOA are highly frequent and often concurrent in AITL, arguing for their potential cooperation in lymphoma development. This evidence concerns the gene RHOA and angioimmunoblastic T-cell lymphoma.